Business / Finance

RSS

SANUWAVE Health raises $4,102,660 from exercise of Options

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, announces that it has raised gross proceeds of $4,102,660 from the exercise of Options that were issued as part of the sale of Units to accredited investors during 2010. The Options had an expiration date of January 31, 2011.

7 Feb 2011

Unison Health Plan of Pennsylvania announces name change to UnitedHealthcare Community Plan

Unison Health Plan of Pennsylvania, based in Monroeville, has joined its Philadelphia-based sister company, AmeriChoice of Pennsylvania, under the name UnitedHealthcare Community Plan. The combined plans serve more than 280,000 health plan members in Pennsylvania.

7 Feb 2011

UHS announces acquisition of Emergent Group and PRI Medical

Universal Hospital Services, Inc. ("UHS"), a leading provider of medical equipment management and service solutions, today announced the signing of a definitive agreement whereby UHS will acquire Emergent Group Inc. and its wholly owned subsidiary, PRI Medical Technologies, Inc., a leading provider of mobile medical lasers and surgical equipment, for $8.46 per Emergent Group share in an all-cash transaction.

7 Feb 2011

Princeton HealthCare System awards OSI Systems $2.3M patient monitoring solutions contract

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received an approximate $2.3 million contract from Princeton HealthCare System.

7 Feb 2011

FTC grants Genoptix early termination of waiting period under HSR Act for Novartis' cash tender offer

Genoptix, Inc. announced today that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act") applicable to the cash tender offer by Novartis to purchase all outstanding shares of common stock of Genoptix at USD$25.00 per share.

7 Feb 2011

Emeritus enters agreement with Columbia Pacific Advisors to manage assisted living and memory care community

Emeritus Corporation, a national provider of senior living services, announced the signing of an agreement with Columbia Pacific Advisors to manage an assisted living and memory care community. This agreement represents the third such agreement entered into between the parties since August 2010 covering three communities with 269 total units.

7 Feb 2011

A.D.A.M. shareholders approve Agreement and Plan of Merger with Ebix

A.D.A.M., Inc., a leading provider of innovative online technology solutions for the health, benefits and education markets, today announced that its shareholders have approved the Agreement and Plan of Merger, dated as of August 29, 2010, by and among A.D.A.M., Ebix, Inc. ("Ebix") and Eden Acquisition Sub, Inc., a direct wholly owned subsidiary of Ebix.

7 Feb 2011

Helix Medical to invest over $4M for new manufacturing facility in Costa Rica

Helix Medical, LLC, a global manufacturer for the medical device and healthcare industries, will soon begin construction on a new medical manufacturing facility in Costa Rica. Helix Medical signed a leasing agreement in The Coyol Free Trade Zone and Business Park in Alajuela, Costa Rica, just outside of San Jose. The company will invest more than $4M in the new plant that will soon employ more than 100 people.

7 Feb 2011

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that they have entered into an exclusive worldwide (except Japan) agreement by which Salix has licensed rights to RELISTOR® (methylnaltrexone bromide).

7 Feb 2011

AMRI fourth quarter total revenue increases 12% to $48.6 million

AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2010.

7 Feb 2011

Humana fourth quarter diluted EPS decreases to $0.63

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended December 31, 2010 (4Q10) of $0.63, compared to $1.48 per share for the quarter ended December 31, 2009 (4Q09).

7 Feb 2011

Viking Systems retains Porter, LeVay & Rose to help communicate company's key initiatives

Viking Systems, a leading worldwide developer, manufacturer and marketer of 2D and 3D visualization solutions for complex minimally invasive surgery, today announced that it has retained Porter, LeVay & Rose, Inc., to advise the Company on its investor relations initiatives.

7 Feb 2011

UHS to acquire Emergent Group/PRI Medical for $70 million

Emergent Group Inc, a leading provider of mobile medical lasers and surgical equipment through its wholly owned subsidiary, PRI Medical Technologies, Inc., today announced that it has signed a definitive agreement with Universal Hospital Services, Inc., whereby UHS will make a cash tender offer of $8.46 per share for all outstanding shares of Emergent Group after a customary "go-shop" period of 21 days.

7 Feb 2011

Synexus wins first contract to conduct ophthalmology studies

Synexus, the world's largest company responsible for the recruitment and running of clinical trials, has won its first contract to conduct ophthalmology studies.

From AES - Accelerated Enrollment Solutions 7 Feb 2011

Pfizer enters definitive agreement to purchase Ferrosan's consumer healthcare business

Pfizer Inc. today announced that it has entered into a definitive agreement to purchase Ferrosan's consumer healthcare business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited.

7 Feb 2011

Cegedim's consolidated fourth quarter 2010 revenues increase 10.1%

Cegedim, a global technology and services company specializing in the healthcare field, generated consolidated Q4 2010 revenues of €266.5 million, a 10.1% increase on a reported basis and up 2.9% like for like. Revenue growth was stronger than the Group had expected, due in large part to an excellent December in every business sector.

5 Feb 2011

General Cannabis subsidiaries show expected success, growth in January 2011

The General Cannabis, Inc. subsidiaries are already showing expected success and growth in the year's first quarter.

5 Feb 2011

Maxygen distributes Codexis's shares to its stockholders for U.S. Federal income tax purposes

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its distributions of Codexis, Inc. common stock and cash in December 2010 will be classified as a return of capital to its stockholders for U.S. Federal income tax purposes.

5 Feb 2011

Pharmacyclics second quarter non-GAAP net loss increases to $6.1 million

Pharmacyclics, Inc. today reported recent developments and financial results for its fiscal second quarter that ended December 31, 2010.

5 Feb 2011

MetaMorphix announces sale under Chapter 11

MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.

5 Feb 2011